![](https://academy.astro.org/sites/default/files/styles/course_image/public/headNeck2020_120x90.jpg?itok=CBHmziwP)
2020 Multidisciplinary Head and Neck Cancers Symposium
This meeting provides the most up-to-date information on multidisciplinary therapies, the latest clinical research, new treatment strategies, supportive care, scientific breakthroughs and toxicity mitigation.
Target Audience
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, immunologist and rehabilitation specialists.
Learning Objectives
- Explain the importance of multidisciplinary care in head and neck cancer and how to best apply it for optimal outcomes.
- Describe key advances in systemic therapy, including targeted therapy and immunotherapy in head and neck cancer.
- Discuss recent advances in minimally invasive surgery in head and neck cancer and when to apply it in treating early and locally advanced disease.
- Describe key advances in radiation therapy delivery, targeting and differences between various modalities, including novel treatment approaches such as proton and FLASH radiotherapy.
- Explain the recent changes in the staging system for head and neck cancer and whether they impact management of certain head and neck cancer subtypes.
- Discuss complex cases in head and neck cancer and how to best utilize current knowledge for decision-making.
- Manage toxicities related to the management of head and neck cancer.
- Summarize key recent advances in head and neck cancer biology.
- Summarize key recent advances in head and neck cancer imaging.
- Discuss and implement standard treatment guidelines for various subtypes of head and neck cancers.
Physicians
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO designates this live activity for a maximum of 17.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME certificates of credit are only available to participants who have completed the online evaluation tool.
Physicists
This activity has been approved for a maximum of 17.5 Medical Physics Continuing Education Credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Program (CAMPEP).
Physicist attendees will receive a confirmation certificate of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting. Your official certificate will be available from CAMPEP.
Available Credit
- 17.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 17.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 17.50 Certificate of AttendanceThis activity was designated for 17.50 AMA PRA Category 1 Credit™.
- 17.50 CAMPEPThis activity has been approved for 17.50 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
Price
Please only evaluate the sessions you attended.
CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants will have online access to their certificate upon completion of the evaluation. Participants can access, print and save their certificate from ASTRO Academy.
Physicist attendees will not receive certificates of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting.